AI assistant
GOOCH & HOUSEGO PLC — Director's Dealing 2021
Jan 7, 2021
7679_def-14a_2021-01-07_5ea1a3df-2ce5-4561-947a-1ed30850321e.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 9526K
Gooch & Housego PLC
07 January 2021
| For immediate release | 7 January 2021 |
Gooch & Housego PLC
("G&H" or the "Company")
Grant of LTIP Awards
Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of optical components & systems, announces that awards were made on 7 January 2021 in accordance with the rules of the Gooch & Housego PLC Long Term Incentive Plan 2013 to the following Directors and Person Discharging Managerial Responsibility ("PDMR") of the Company:
| Name | Position | Number of Awards Granted in January 2021 |
| Mark Webster | Chief Executive Officer | 32,835 |
| Chris Jewell | Chief Financial Officer | 22,839 |
| Gareth Crowe | Company Secretary | 3,340 |
Subject to satisfying the required TSR and EPS performance criteria these grants will vest on 7 January 2024.
In addition to the above awards, the following one-time awards have been made to the following Directors and PDMR which will vest on 7 January 2023 subject to satisfying the required EPS performance criteria.
| Name | Position | Number of Awards Granted in January 2021 |
Total Number of Unvested Awards |
| Mark Webster | Chief Executive Officer | 21,890 | 111,343 |
| Chris Jewell | Chief Financial Officer | 18,686 | 79,392 |
| Gareth Crowe | Company Secretary | 1,670 | 16,436 |
Further details of the performance and vesting criteria are set out in the Company's 2020 Annual Report & Accounts, which can be found on the Company's website at https://gandh.com/investors/
| For further information contact: | ||
| Mark Webster / Chris Jewell | Gooch & Housego PLC | 01460 256440 |
| Mark Court / Charlotte Slater | Buchanan | 020 7466 5000 |
| Christopher Baird / Patrick Robb / David Anderson | Investec Bank plc | 020 7597 5970 |
Notes to editors
Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | 1. Mark Webster 2. Chris Jewell 3. Gareth Crowe |
||||
| 2 | Reason for the notification | |||||
| a) | Position/status | 1. Chief Executive Officer 2. Chief Financial Officer 3. Company Secretary |
||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Gooch & Housego Plc | ||||
| b) | LEI | 213800DO3D00KYOPA952 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument. Identification code |
Ordinary shares of 20 pence each GB0002259116 |
||||
| b) | Nature of transaction | Awards made pursuant to the rules of the Gooch & Housego PLC Long Term Incentive Plan 2013 | ||||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |||
| n/a | 1. 54,725 2. 41,525 3. 5,010 |
|||||
| Aggregated information - Aggregated volume - Price |
1. 54,725 2. 41,525 3. 5,010 n/a |
|||||
| e) | Date of the transaction | 7 January 2021 | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAAFXEFSFEFA